Publication | Open Access
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials
112
Citations
33
References
2023
Year
Skin CancerMedicineOpacin-neo TrialsImmunologyMelanomaImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologySurvival Update
| Year | Citations | |
|---|---|---|
Page 1
Page 1